An Indirect Treatment Comparison of Cabozantinib Verse Vandetanib in Progressive Medullary Thyroid Cancer (MTC)
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2173
https://www.valueinhealthjournal.com/article/S1098-3015(14)04103-5/fulltext
Title :
An Indirect Treatment Comparison of Cabozantinib Verse Vandetanib in Progressive Medullary Thyroid Cancer (MTC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04103-5&doi=10.1016/j.jval.2014.08.2173
First page :
A616
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1632